A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis

一项 2a 期开放标签临床试验，旨在确定泛昔洛韦对多发性硬化症患者唾液中 EBV 脱落量测量的 EBV 活性的影响